HEALTHCARE

The healthcare practice group of Stonebridge Technology Associates focuses exclusively on addressing the unique investment banking needs of medical device, diagnostic, life science, and other healthcare technology product and service companies. 

Stonebridge’s healthcare bankers have successfully executed transactions on behalf of companies across the development spectrum ranging from early stage, pre-revenue private companies, to later stage, publicly-traded entities. In addition, our professionals have worked closely with clients operating across a variety of healthcare sectors, including, among others:

  • Biotechnology
  • Biomaterials
  • Clinical Diagnostics
  • Diagnostic Imaging
  • Healthcare Information Providers
  • Healthcare Information Systems
  • Healthcare Service Providers
  • Medical Devices/Equipment
  • Pharmaceuticals
  • Therapeutics


Appreciation of Unique Client Needs
Stonebridge’s healthcare investment banking team combines knowledge of the unique technology, market and regulatory issues that confront healthcare companies with the financial acumen and transaction experience needed to execute complicated and highly structured transactions.   

Our success in serving the needs of such clients has been driven by our approach of developing a comprehensive understanding of healthcare-specific and general business issues such as:

  • Clinical validation and its impact on the company’s overall market opportunity

  • Intellectual property and how these assets translate into tangible business value

  • Regulatory strategy and how clinical milestones and regulatory approvals drive business value

  • Competitive positioning and the relative strengths and weaknesses of existing industry participants and new market entrants

  • Partnership opportunities in such areas technology licensing, co-development of products and distribution arrangements

  • Reimbursement and cost of care issues and their impact on the business model and ability to obtain market penetration

Strategic Partnerships and Licensing Opportunities
More than in most industries, medical technology and biopharmaceutical firms rely on collaborative business partnerships, including licensing, co-development, funded development, marketing and distribution arrangements, and joint ventures. Stonebridge’s healthcare team actively assists its clients’ business partnering efforts by performing financial analyses, identifying potential partners, leading or assisting negotiations, and providing informed strategic advice in support of the evaluation and execution of these collaborations.

Integrated Advisory Capability
Our combined capital raising and merger and acquisition expertise enables us to deliver an integrated advisory capability that allows our healthcare clients to explore various strategic options simultaneously. This capability has proven to be extremely valuable to clients interested in pursuing a parallel-path strategy that allows them to simultaneously compare the relative benefits of raising growth capital from an institutional or strategic investor, entering into broad or specific collaborative relationships, or exiting via an outright sale of the company.